Clinical Considerations of the Role of Palbociclib in the Management of Advanced Breast Cancer Patients With and Without Visceral Metastases.
Author | |
---|---|
Abstract | :
This report assesses the efficacy and safety of palbociclib plus endocrine therapy (ET) in women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer (ABC) with or without visceral metastases. |
Year of Publication | :
2018
|
Journal | :
Annals of oncology : official journal of the European Society for Medical Oncology
|
Date Published | :
2018
|
ISSN Number | :
0923-7534
|
URL | :
https://academic.oup.com/annonc/article-lookup/doi/10.1093/annonc/mdx797
|
DOI | :
10.1093/annonc/mdx797
|
Short Title | :
Ann Oncol
|
Download citation |